Gordon N. Gill

Q: What Schools Are Affiliated With Gordon N. Gill

Gordon N. Gill is affiliated with the following schools: University of California, San Diego, Baylor College of Medicine

Gordon N. Gill's AcademicInfluence.com Rankings

Gordon N. Gill

Biology

#9280

World Rank

#12466

Historical Rank

Cell Biology

#389

World Rank

#399

Historical Rank

Neuroscience

#1345

World Rank

#1391

Historical Rank

Biochemistry

#1401

World Rank

#1525

Historical Rank

biology Degrees

Download Badge

Biology

Gordon N. Gill's Degrees

PhD Biochemistry Stanford University
Bachelors Chemistry University of California, Berkeley

Why Is Gordon N. Gill Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gordon N. Gill's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics (1999) (1096)
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. (1994) (955)
The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling* (1997) (620)
C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. (1984) (549)
Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor (1987) (528)
Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. (1990) (402)
Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells (1981) (382)
Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. (1984) (369)
Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. (1984) (364)
Enhanced Degradation of EGF Receptors by a Sorting Nexin, SNX1 (1996) (361)
Regulated Migration of Epidermal Growth Factor Receptor from Caveolae* (1999) (330)
LIM Factor Lhx3 Contributes to the Specification of Motor Neuron and Interneuron Identity through Cell-Type-Specific Protein-Protein Interactions (2002) (326)
A cyclic-3',5'-adenosine monophosphate dependent protein kinase from the adrenal cortex: comparison with a cyclic AMP binding protein. (1970) (304)
Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation (1989) (302)
The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. (1991) (287)
Protein-Protein Interaction of Zinc Finger LIM Domains with Protein Kinase C* (1996) (244)
Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. (1984) (242)
Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms (1986) (241)
Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. (1996) (239)
Inhibition of the receptor‐binding function of clathrin adaptor protein AP‐2 by dominant‐negative mutant μ2 subunit and its effects on endocytosis (1999) (232)
On the mechanism of action of ACTH. (1971) (231)
Small CTD Phosphatases Function in Silencing Neuronal Gene Expression (2005) (220)
RGS-PX1, a GAP for Gαs and Sorting Nexin in Vesicular Trafficking (2001) (220)
A Novel RNA Polymerase II C-terminal Domain Phosphatase That Preferentially Dephosphorylates Serine 5* (2003) (211)
Receptor tyrosine kinases (1992) (209)
Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies (1988) (201)
Epidermal growth factor and its receptor (1987) (198)
Functional analysis of the nuclear LIM domain interactor NLI (1997) (183)
Production of an epidermal growth factor receptor-related protein. (1984) (178)
Control of bovine adrenal cortical cell proliferation by fibroblast growth factor. Lack of effect of epidermal growth factor. (1977) (171)
The Nuclear LIM Domain Interactor NLI Mediates Homo- and Heterodimerization of LIM Domain Transcription Factors* (1998) (170)
Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor on Tyrosine 845 Is Required for Zinc-induced Ras Activation* (2002) (161)
Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. (1990) (160)
The Grainyhead-like epithelial transactivator Get-1/Grhl3 regulates epidermal terminal differentiation and interacts functionally with LMO4. (2006) (159)
Endosomal localization and function of sorting nexin 1 (2002) (153)
Endocytosis and Lysosomal Targeting of Epidermal Growth Factor Receptors Are Mediated by Distinct Sequences Independent of the Tyrosine Kinase Domain (*) (1995) (144)
Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice. (1986) (142)
Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor. (1985) (142)
Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation. (1984) (142)
Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression (1990) (129)
Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation. (1990) (128)
Angiotensin stimulation of bovine adrenocortical cell growth. (1977) (123)
Mitogenic Signaling by Ret/ptc2 Requires Association with Enigma via a LIM Domain* (1996) (120)
Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides (2001) (119)
Hormonal control of adrenocortical cell proliferation. Desensitization to ACTH and interaction between ACTH and fibroblast growth factor in bovine adrenocortical cell cultures. (1977) (119)
Chip and apterous physically interact to form a functional complex during Drosophila development. (1999) (118)
The EGF receptor: structure, regulation and potential role in malignancy. (1985) (114)
LIM domain recognition of a tyrosine-containing tight turn. (1994) (114)
Interaction between the epidermal growth factor receptor and phosphoinositide kinases. (1991) (113)
Determinants for dephosphorylation of the RNA polymerase II C‐terminal domain by Scp1 (2006) (109)
Role of epidermal growth factor‐stimulated protein kinase in control of proliferation of A431 cells (1982) (107)
The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface. (2004) (106)
Role of the receptor in the mechanism of action of adenosine 3':5'-cyclic monophosphate. (1971) (105)
Nucleotide regulation of a eukaryotic protein synthesis initiation complex;. (1975) (104)
Regulation of the ERBB-2 Promoter by RBPJκ and NOTCH* (1997) (102)
Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis. (1998) (102)
Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2 (1998) (102)
Structure and function of LIM domains. (1998) (98)
Specificity of LIM Domain Interactions with Receptor Tyrosine Kinases* (1996) (98)
The PDZ Domain of the LIM Protein Enigma Binds to β-Tropomyosin (1999) (97)
Association of Epidermal Growth Factor Receptors with Coated Pit Adaptins via a Tyrosine Phosphorylation-regulated Mechanism (*) (1995) (96)
Ligand-induced endocytosis of epidermal growth factor receptors that are defective in binding adaptor proteins. (1995) (95)
Structural Features of LIM Kinase That Control Effects on the Actin Cytoskeleton* (1999) (95)
Regulation of the fetal human adrenal cortex: effects of adrenocorticotropin on growth and function of monolayer cultures of fetal and definitive zone cells. (1981) (93)
A site of tyrosine phosphorylation in the C terminus of the epidermal growth factor receptor is required to activate phospholipase C (1992) (92)
A negative feedback loop attenuates EGF-induced morphological changes (1991) (89)
Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation. (1988) (87)
Phosphorylation of cardiac troponin by guanosine 3':5'-monophosphate-dependent protein kinase. (1978) (86)
Endocytosis and mitogenic signaling. (1999) (85)
A three-step purification procedure for protein kinase C: characterization of the purified enzyme. (1987) (82)
Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF. (1982) (81)
Purification and characterization of 3':5'-cyclic GMP-dependent protein kinase. (1976) (79)
Islet-to-LMO stoichiometries control the function of transcription complexes that specify motor neuron and V2a interneuron identity (2009) (79)
Growth and function of cultured bovine adrenocortical cells in a serum-free defined medium. (1982) (78)
Mechanism of ACTH action. (1972) (77)
Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor. (1993) (75)
The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation. (1994) (75)
Characterization of adult bovine adrenocortical cells throughout their life span in tissue culture. (1978) (75)
Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo. (1988) (74)
RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking. (2001) (73)
Characterization of cultured bovine adrenocortical cells and derived clonal lines: regulation of steroidogenesis and culture life span. (1979) (72)
Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the epidermal growth factor receptor. (1990) (71)
Coexpression of both alpha and beta subunits is required for assembly of regulated casein kinase II. (1991) (71)
Metyrapone and antioxidants are required to maintain aldosterone synthesis by cultured bovine adrenocortical zona glomerulosa cells. (1982) (70)
The enigma of LIM domains. (1995) (70)
Phosphorylation of ribosome-associated protein by an adenosine 3':5'-cyclic monophosphate-dependent protein kinase: location of the microsomal receptor and protein kinase. (1971) (69)
Structural analysis of the transmembrane domain of the epidermal growth factor receptor. (1991) (69)
T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites. (1993) (69)
Activation of the purified protein tyrosine kinase domain of the epidermal growth factor receptor. (1989) (68)
Guanosine 3':5'-monophosphate-dependent protein kinase from bovine lung. Subunit structure and characterization of the purified enzyme. (1977) (66)
The LIM domain-only protein LMO4 is required for neural tube closure (2005) (65)
The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells (2007) (64)
Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. (1990) (61)
Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent. (1995) (60)
Ribonuclease H (hybrid) in Escherichia coli. Identification and characterization. (1973) (58)
Viewing serine/threonine protein phosphatases through the eyes of drug designers (2013) (57)
The PDZ domain of the LIM protein enigma binds to beta-tropomyosin. (1999) (57)
Regulation of epidermal growth factor receptor gene expression. (1989) (57)
Anti-pp60src antibodies are substrates for EGF-stimulated protein kinase (1981) (56)
Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH. (1997) (55)
Chip is an essential cofactor for apterous in the regulation of axon guidance in Drosophila. (2000) (55)
Enhanced tumorigenesis of NR6 cells which express non-down-regulating epidermal growth factor receptors. (1991) (52)
On the mechanism of action of adrenocorticotropic hormone: the binding of cyclic-3',5'-adenosine monophosphate to an adrenal cortical protein. (1969) (51)
Differential effects of ACTH or 8‐Br‐cAMP on growth and replication in a functional adrenal tumor cell line (1977) (51)
Regulation of ternary (Met-tRNAf - GTP - eukaryotic initiation factor 2) protein synthesis initiation complex formation by the adenylate energy charge. (1976) (51)
Ligand-induced internalization and increased cell calcium are mediated via distinct structural elements in the carboxyl terminus of the epidermal growth factor receptor. (1991) (50)
Induction of cultured bovine adrenocortical zona glomerulosa cell 17-hydroxylase activity by ACTH (1983) (49)
Guanosine 3',5'-monophosphate-dependent protein kinase. (1979) (48)
The product of the MLD gene is a member of the membrane fatty acid desaturase family: overexpression of MLD inhibits EGF receptor biosynthesis. (1997) (48)
Regulation of the epidermal growth factor receptor by phosphorylation (1985) (47)
Structural analysis of cGMP-dependent protein kinase using limited proteolysis. (1980) (46)
Separation and characterization of a phosphatidylinositol kinase activity that co-purifies with the epidermal growth factor receptor. (1985) (46)
Structure and inducible regulation of the human c-erb B2/neu promoter. (1990) (45)
Regulation of deoxyribonucleic acid synthesis in bovine adrenocortical cells in culture. (1979) (44)
Regulation of glutamine and pyruvate oxidation in cultured adrenocortical cells by cortisol, antioxidants, and oxygen: Effects on cell proliferation (1981) (44)
Activation of hormone-sensitive lipase and phosphorylase kinase by purified cyclic GMP-dependent protein kinase. (1977) (43)
Determinants of the endosomal localization of sorting nexin 1. (2005) (43)
Phosphorylation of high mobility group protein 14 by casein kinase II. (1985) (42)
Positive cooperativity in guanosine 3':5'-monophosphate binding to guanosine 3':5'-monophosphate-dependent protein kinase. (1979) (42)
Suppression of cultured bovine adrenocortical zona glomerulosa cell aldosterone synthesis by steroids and its prevention by antioxidants. (1983) (41)
Structural and functional analysis of the phosphoryl transfer reaction mediated by the human small C‐terminal domain phosphatase, Scp1 (2010) (41)
Relationship between production of epidermal growth factor receptors, gene amplification, and chromosome 7 translocation in variant A431 cells (1985) (40)
Adenosine 3',5'-monophosphate and protein kinase dependent phosphorylation of ribosomal protein. (1973) (39)
Phosphorylation of high mobility group 14 protein by cyclic nucleotide-dependent protein kinases. (1982) (35)
ACTH regulation of the adrenal cortex. (1976) (34)
Identity of the in vivo phosphorylation site in high mobility group 14 protein in HeLa cells with the site phosphorylated by casein kinase II in vitro. (1983) (33)
Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factor (1983) (33)
Aging of adrenocortical cells in culture. (1979) (30)
Purification of the cAMP receptor protein by affinity chromatography. (1974) (29)
Decoding the LIM development code. (2003) (28)
A nuclear protein is required for thyroid hormone receptor binding to an inhibitory half-site in the epidermal growth factor receptor promoter. (1992) (28)
Preferential regulation of protein synthesis initiation complex formation by purine nucleotides. (1976) (25)
Regulation of EGF receptor expression and function (1990) (25)
Hormonal regulation of initiation of DNA synthesis and of differentiated function in Y‐1 adrenal cortical cells (1977) (24)
Regulation of cyclic nucleotide-dependent protein kinase activity by histones and poly(L-arginine). (1981) (23)
Hormonal control of adrenal RNA polymerase activities. (1974) (23)
Epidermal growth factor stimulates phosphorylation of RAF-1 independently of receptor autophosphorylation and internalization. (1991) (23)
Regulation of responsiveness of cultured adrenal cells to adrenocorticotropin and prostaglandin E1: cell density, cell division, and inhibitors of protein synthesis. (1981) (22)
Involvement of ErbB2 in the Signaling Pathway Leading to Cell Cycle Progression from a Truncated Epidermal Growth Factor Receptor Lacking the C-terminal Autophosphorylation Sites (*) (1996) (21)
Receptor protein tyrosine kinases (2007) (21)
A Pit Stop at the ER (2002) (20)
Regulatory features of the epidermal growth factor receptor (1987) (20)
Adrenocorticotropic hormone stimulation of adrenal RNA polymerase I and III activities. Nucleotide incorporation into internal positions and 3' chain termini. (1975) (20)
THE ISOLATION OF A RECEPTOR FOR ADENOSINE 3′,5′‐CYCLIC MONOPHOSPHATE (cAMP) FROM THE ADRENAL CORTEX: THE ROLE OF THE RECEPTOR IN THE MECHANISM OF ACTION OF cAMP * (1971) (19)
Positive and negative regulatory elements in the human erbB-2 gene promoter. (1994) (19)
Role of intrinsic protein tyrosine kinase in function and metabolism of the epidermal growth factor receptor. (1988) (19)
The use of affinity chromatography in purification of cyclic nucleotide receptor proteins. (1976) (19)
Thyrotropin-stimulated phosphorylation of high mobility group protein 14 in vivo at the site catalyzed by cyclic nucleotide-dependent protein kinases in vitro. (1984) (18)
Comparison of cyclic nucleotide specificity of guanosine 3',5'-monophosphate-dependent protein kinase and adenosine 3',5'-monophosphate-dependent protein kinase. (1979) (17)
A Heterodimeric Nuclear Protein Complex Binds Two Palindromic Sequences in the Proximal Enhancer of the Human erbB-2 Gene (*) (1996) (17)
Protein effects on the activity of guanosine 3':5'-monophosphate-dependent protein kinase. (1980) (16)
Guanosine 3',5'-monophosphate receptor protein: separation from adenosine 3',5'-monophosphate receptor protein. (1975) (16)
Purification of functionally active epidermal growth factor receptor protein using a competitive antagonist monoclonal antibody and competitive elution with epidermal growth factor. (1987) (15)
Reversibility of the epidermal growth factor receptor self-phosphorylation reaction. Evidence for formation of a high energy phosphotyrosine bond. (1989) (14)
Hormonal regulation of the adrenocortical cell. (1980) (13)
Assay of cyclic nucleotide-dependent protein kinases. (1979) (13)
Kinetics of cAMP inhibition of DNA synthesis in bovine adrenocortical cells (1980) (12)
Effect of carboxyl terminal truncation on the tyrosine kinase activity of the epidermal growth factor receptor. (1992) (12)
Adrenocorticotropic hormone regulation of adrenal RNA polymerases. Stimulation of nuclear RNA polymerase III. (1976) (12)
Specific factors are required for kinase-dependent endocytosis of insulin receptors. (1994) (12)
Expression and purification of the epidermal growth factor receptor extracellular domain utilizing a polycistronic expression system. (1993) (11)
Regulation of gene expression by epidermal growth factor. (1991) (9)
Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor (1984) (9)
Mutational Analysis of the Nucleotide Binding Site of the Epidermal Growth Factor Receptor and v-Src Protein-tyrosine Kinases* (1996) (9)
The detection and characterization of cyclic AMP-receptor proteins in animal cells. (1974) (9)
Hormone Receptor Regulation of the Human Immunodeficiency Virus Type 1 and Type 2 Long Terminal Repeats. (1996) (9)
Comparison of cyclic nucleotide binding to adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate-dependent protein kinases. (1979) (8)
Analysis of substrate recognition determinants in a synthetic peptide containing the Tyr 1173 autophosphorylation site of the epidermal growth factor receptor. (1995) (7)
Purification and properties of thyroid hormone receptor beta 1 expressed in Escherichia coli as a fusion protein. (1995) (7)
Epidermal growth factor stimulates a protein tyrosine kinase which is separable from the epidermal growth factor receptor. (1993) (7)
Bio-molecular architects: a scaffold provided by the C-terminal domain of eukaryotic RNA polymerase II (2010) (7)
3 Growth Factors and Their Receptors (1989) (7)
Pharmacology of adrenal cortical hormones (1979) (6)
Structural features of the 5' region of the human erbB-2 gene. (1993) (5)
Analysis of functional domains in the epidermal growth factor receptor using site-directed mutagenesis. (1988) (5)
Nucleotide regulation of protein synthesis. (1979) (3)
Corrections - Adrenocorticotropic Hormone Regualtion of Adrenal RNA Poymerases. Stimulation of Nuclear RNA Polymerase III. (1977) (2)
A comparison of the cyclic nucleotide-dependent protein kinases using chemical cleavage at tryptophan and cysteine. (1985) (2)
A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase. (1999) (2)
Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis (LHX genesynuclear LIM interactorycranial neural crestySchwann cellsysomite) (1998) (2)
Loss of division potential in culture: aging or differentiation? (1980) (2)
LIM Domain Genes (2001) (1)
Adrenal Cortical Ribonuclease H (Hybrid) 1 (1975) (1)
Comparison of the interaction of cyclic nucleotide-dependent protein kinases with mononucleosomes and free histones. (1981) (1)
Protein modulation of cyclic nucleotide-dependent protein kinases. (1983) (1)
Evolution of hormone-receptor systems : proceedings of the UCLA symposium held in Squaw Valley, California, March 14-20, 1982 (1983) (1)
STUDIES OF THE cAMP RECEPTOR PROTEIN AND OF THE cAMP DEPENDENT PHOSPHORYLATION OF RIBOSOMAL PROTEIN (1973) (1)
A hypothesis concerning the structure of cAMP-and cGMP-dependent protein kinases. (1977) (1)
Identification of phosphorylation sites: use of the epidermal growth factor receptor. (1991) (1)
Comparison of cAMP-dependent protein kinase in normal and Rous sarcoma virus transformed chick embryo fibroblasts. (1981) (1)
[21] Protein modulation of cyclic nucleotide-dependent protein kinases (1983) (1)
Molecular Recognition of Endocytic Codes in Receptor Tyrosine Kinases. (1995) (0)
Adrenal Cortical Ribonuclease H (hybrid) (38494). (1975) (0)
Effects of Epidermal Growth Factor Receptor Concentration on Tumorigenicity of A431 Cells in Nude Mice1 (2006) (0)
Removal of the tyrosine kinase domain leads to constitutive internalization and lysosomal targeting of the EGF receptor (1993) (0)
Growth factors, receptors and oncogenes. (1988) (0)
FACTOR RECEPTOR USING SITE-DIRECTED MUTAGENESIS (1988) (0)
Structure Functional analysis of the epidermal growth factor receptor (1993) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gordon N. Gill?

Gordon N. Gill is affiliated with the following schools:

Gordon N. Gill's Academic­Influence.com Rankings

Gordon N. Gill's Degrees

Why Is Gordon N. Gill Influential?

Gordon N. Gill's Published Works

Published Works

What Schools Are Affiliated With Gordon N. Gill?

Gordon N. Gill's AcademicInfluence.com Rankings